Baird Medical Investment Holdings (BDMD) Common Equity (2023 - 2025)

Baird Medical Investment Holdings' Common Equity history runs 3 years deep, the most recent figure standing at $31.2 million for Q4 2025.

• In Q4 2025, Common Equity fell 21.47% year-over-year to $31.2 million; the TTM figure through Dec 2025 stood at $31.2 million (down 21.47% YoY), while the FY2025 annual figure was $31.2 million, down 21.47% from the prior year.
• Common Equity was $31.2 million for Q4 2025 at Baird Medical Investment Holdings, down from $35.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $39.8 million in Q4 2024 to a low of $31.2 million in Q4 2025.
• Historically, Common Equity has averaged $35.6 million across 3 years, with a median of $35.7 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Common Equity rose 11.35% in 2024, then slipped 21.47% in 2025.
• A 3-year view of Common Equity shows it stood at $35.7 million in 2023, then advanced by 11.35% to $39.8 million in 2024, then declined by 21.47% to $31.2 million in 2025.
• The last three Common Equity figures came in at $31.2 million (Q4 2025), $35.6 million (Q2 2025), and $39.8 million (Q4 2024), per Business Quant data.